TNF Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNFA and other ETFs, options, and stocks.

About TNFA

TNF Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. 

CEO
Christopher C. Chapman, Jr., MD
CEOChristopher C. Chapman, Jr., MD
Employees
2
Employees2
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1989
Founded1989
Employees
2
Employees2

TNFA Key Statistics

Market cap
2.17M
Market cap2.17M
Price-Earnings ratio
-0.02
Price-Earnings ratio-0.02
Dividend yield
Dividend yield
Average volume
4.62M
Average volume4.62M
High today
$0.1915
High today$0.1915
Low today
$0.1509
Low today$0.1509
Open price
$0.183
Open price$0.183
Volume
3.25M
Volume3.25M
52 Week high
$2.24
52 Week high$2.24
52 Week low
$0.1509
52 Week low$0.1509

People also own

Based on the portfolios of people who own TNFA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.